BNTC financials

Benitec Biopharma (BNTC) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

BNTC income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2026––-$51.19M-$45.55M-1.69
2025––-$41.77M-$37.92M-1.81
2024$0.00–-$22.49M-$22.37M-2.11
2023$75.00K–-$19.08M-$19.56M-5.39
2022$73.00K–-$17.85M-$18.21M-14.46
2021$59.00K–-$13.60M-$13.88M-20.97